Search research articles
Contact Us
Filters
Showing results (21-30 of 39) with videos related to
Page
of 4
Sort By:
Journal of Affective Disorders
|
November 12, 2009
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
Trisha Suppes, Catherine Datto, Margaret Minkwitz, et al.
Journal of Affective Disorders
|
December 25, 2014
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
Trisha Suppes, Catherine Datto, Margaret Minkwitz, et al.
Journal of Pain Research
|
June 9, 2018
Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery
Eric T Wittbrodt, Tong J Gan, Catherine Datto, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 23, 2016
The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports
Robert J LoCasale, Catherine Datto, Hilary Wilson, et al.
Depression and Anxiety
|
August 25, 2010
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
Michael Liebowitz, Raymond W Lam, Ulla Lepola, et al.
Journal of Opioid Management
|
July 26, 2018
Efficacy and safety of naloxegol for opioid-induced constipation assessed by specific opioid medication, opioid dose, and duration of opioid use
Srinivas Nalamachu, Jeffrey Gudin, Catherine Datto, et al.
Clinical Therapeutics
|
November 8, 2011
Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial
Andrew J Cutler, Catherine Datto, Arvid Nordenhem, et al.
International Clinical Psychopharmacology
|
October 29, 2013
Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels
Stuart A Montgomery, A Carlo Altamura, Heikki Katila, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
April 10, 2013
Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder
Heikki Katila, Irina Mezhebovsky, Amy Mulroy, et al.
Journal of the American Geriatrics Society
|
January 20, 2006
Simvastatin causes changes in affective processes in elderly volunteers
Knashawn Morales, Marsha Wittink, Catherine Datto, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 39) with videos related to
Sort By:
Page
of 4
Journal of Affective Disorders
|
November 12, 2009
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
Trisha Suppes, Catherine Datto, Margaret Minkwitz, et al.
Journal of Affective Disorders
|
December 25, 2014
Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression
Trisha Suppes, Catherine Datto, Margaret Minkwitz, et al.
Journal of Pain Research
|
June 9, 2018
Resource use and costs associated with opioid-induced constipation following total hip or total knee replacement surgery
Eric T Wittbrodt, Tong J Gan, Catherine Datto, et al.
Journal of Managed Care & Specialty Pharmacy
|
March 23, 2016
The Burden of Opioid-Induced Constipation: Discordance Between Patient and Health Care Provider Reports
Robert J LoCasale, Catherine Datto, Hilary Wilson, et al.
Depression and Anxiety
|
August 25, 2010
Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial
Michael Liebowitz, Raymond W Lam, Ulla Lepola, et al.
Journal of Opioid Management
|
July 26, 2018
Efficacy and safety of naloxegol for opioid-induced constipation assessed by specific opioid medication, opioid dose, and duration of opioid use
Srinivas Nalamachu, Jeffrey Gudin, Catherine Datto, et al.
Clinical Therapeutics
|
November 8, 2011
Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial
Andrew J Cutler, Catherine Datto, Arvid Nordenhem, et al.
International Clinical Psychopharmacology
|
October 29, 2013
Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels
Stuart A Montgomery, A Carlo Altamura, Heikki Katila, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
April 10, 2013
Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder
Heikki Katila, Irina Mezhebovsky, Amy Mulroy, et al.
Journal of the American Geriatrics Society
|
January 20, 2006
Simvastatin causes changes in affective processes in elderly volunteers
Knashawn Morales, Marsha Wittink, Catherine Datto, et al.
Page
of 4